BMY-28190, an antibiotic complex active against herpes simplex virus type 1 (HSV-1) was produced by the cultured broth of Streptoalloteichus Mndustanus sp. nov., a producing strain of tallysomycins A and B1}. The antibiotic complex was recovered from the broth with Amberlite IRC-50 resin and separated from the coproduced tallysomycins and nebramycins by a series of chromatographies. BMY-28190exhibited weak inhibitory activity toward Gram-positive and Gram-negative bacteria and strong inhibitory activity toward HSV-1. Structural studies disclosed that BMY-28190is a novel complex of f-poly-D-a:,r-diaminobutyric acids with an average MWof 5,130.
In an earlier paper1}, we reported isolation of newantitumor antibiotics, tallysomycins A and B, and the aminoglycoside antibiotic nebramycin from the cultured broth of Streptoalloteichus Mndustanus E465-94. In our search for antiviral antibiotics amongmicrobial metabolites, the broth of this strain showed strong activity toward herpes simplex virus type 1 (HSV-1) which was not caused by the tallysomycins or nebramycins. BMY-28190, the active principle was isolated from the broth by a weakly acidic ion exchange resin and purified by column cforomatography using a similar type ion exchanger and silica gel. BMY-28190is a novel complex ofj-homopolymers of D-a,?--diammobutyric acid (D-er^-DAB) and exhibits strong inhibition against HSV-1. This paper describes isolation, physico-chemical properties, structure and biological activity of BMY-28190.
Production and Isolation
Taxonomic studies on S. Mndustanus E465-94 (ATCC31158) have been reported2). The strain was cultivated as described^and the harvested broth (30 liters, pH 7.5) was centrifuged. The clear supernate was applied on a column of Amberlite IRC-50 (NH4+ type, 3 liters) which was developed with water, 0.01 n NH4OH,0.25 n NH4OHand then with 1.0n HC1 successively. The antiviral activity and nebramycins were eluted by 0.25 n NH4OHand tallysomycins A and B by 1.0 n HCl. The fractions containing BMY-28190 were concentrated in vacuo, and the residue was chromatographed on a column of Amberlite CG-50 (NH4+ type, 2x64 cm). After washing with water and elution of most of the nebramycins with 0.1 n NH4OH, the antiviral activity was eluted with 0.4 n NH40H. Upon monitoring the eluate by TLC (SiO2, CHC13 -MeOH-28% NH4OH-H2O, 1 :4 :2 : 1), the fractions containing BMY-28190were pooled and evaporated in vacuo to afford a semi-pure sample (870 mg). This solid was rechromatographed on a Silica gel column (Wako C-200, 1.5 x35 cm) with elution by CHC13-MeOH-28%NH4OH-H2O (1 :4:2: 1) mixture first and then of the upper layer of CHCI3-MeOH-28% NH4OH(1 : 1 : 1). The relevant fractions were concentrated, and the concentrate was applied on a column of Sephadex G-25 (1.0 x 30 cm) for desalting. Elution was carried out with water, and the course of elution was followed by the TLC as described above. Evaporation of the appropriate fractions yielded a white solid of homogeneous BMY-28190 (54 mg).
Physico-chemical Properties
Physico-chemical data for BMY-28190are summarized in Table 1 . BMY-28190 is readily soluble in water and dimethyl sulfoxide, slightly soluble in methanol and ethanol and practically insoluble in other organic solvents. It gave positive response to ninhydrin, Dragendorff, Rydon-Smith reagents but negative to ferric chloride and anthrone reagents. BMY-28190does not exhibit absorption in the UV and visible region. The IR spectrum (Fig. 1 ) indicated amino (3400 cm"1) and amide (1640 and 1540 cm"1) functionalities.
BMY-28190is a complex of several components with similar properties, as depicted in the HPLC (Fig. 2) .
Structural Studies
As revealed by HPLC, BMY-28190is a complex of several components; an average MWof 5,700 was obtained by gel filtration using Sephadex G-50. BMY-28190 was hydrolyzed with 6 n HC1 under reflux for 18 hours. The hydrolysate contained only one ninhydrin-positive substance whose be- The XH NMRof BMY-28190 (Fig. 3) resembled that of DABexhibiting only two multiplet signals centered at 2.00 (2H) and 3.43 ppm (3H). Uponacidification, one proton of the latter signal underwent down-field shift (J 0.48 ppm) and appeared as a triplet. In accordance with the AH NMR, the 13C NMR of BMY-28190 showed four carbon signals at 34.2 (t), 36.7 (t), 53. 3 (d) and 177.1 ppm (s) which corresponded well to those of DAB. Whendetermined at pD 2.0, the higher field methylene and carbonyl carbons Tosoh Co. TSK Gel 3000 SW (7.5x600mm). 1/15 m phosphate buffer, pH 7.0. 0.7 ml/minute, UV at 210nm. Antiviral activity of BMY-28190was assessed by the plaque reduction assay and dye-uptake assay9) using the HSV-1-vero cell system. e-Poly-L-lysine10), a structurally related agent produced by Streptomyces No. 346 and two types of synthetic a-poly-L-lysine (MW3,500 and 25,000) were tested comparatively as reference compounds. The results are shown in Table 2 together with their cytotoxicity against host cells. By plaque reduction assay, BMY-28190was the most potent among the compounds tested, showing an ID50 of 0.84^g/ml. s-Poly-L-lysine and higher molecular a:-poly-L-rysine were slightly less active than IBMY-28190, and lower molecular a-poly-L-lysine was the least active. BMY-28190 and s-poly-L-lysine were comparably active by the dye-uptake assay, while the two a-poly-L-lysines were nearly inactive.
BMY-28190 showed relatively weak cytotoxicity and had the best selectivity in these assay systems. Antibacterial Activity
The in vitro antibacterial activity of BMY-28190 was determined by the 2-fold serial broth dilution method in nutrient broth using s-poly-Llysine and a-poly-L-lysine (MW3,500) as reference compounds. As shown in Table 3 , these three compoundsexhibited moderate inhibitory activity against Gram-positive and Gram-negative bacteria with a similar antibacterial spec- trum. In terms of MICs, BMY-28190was comparably active to s-poly-L-lysine against Staphylococcus aureus, Escheriehia coll and Klebslella pneumonlae but less active than s-poly-L-lysine against other organisms. ct-Poly-L-lysine was the least active against all test strains.
Acute Toxicity
The LD50 of BMY-28190 was 22.6 mg/kg following intramuscular administration to male ddY mice.
Partial Acid Hydrolysis of BMY-28190and Anti-HSV-1 Activity of the Products In order to examine the relationship between peptide chain length and antiviral activity, partial acid hydrolysis of BMY-28190was carried out by heating with 6 n HC1 at 100°C for 1 hour. The hydrolysate was chromatographed on a CM-cellulose column to yield 8 peptide fragments. Numbers of D-a,f-DAB in each peptide were determined by the DNPmethod as described before, and antiviral activity against HSV-1 was assessed by dye-uptake assay (Table 4) . Small peptides with less than 12 D-a:,f-DAB residues were practically inactive against the viruses, while peptide fragments 6, 7 and 8 having more than 15 amino acids showed weak antiviral activity. Potency increased with the length of the peptide chain. BMY-28190was more active than these peptides. antiviral activity against HSV-1in our test system. BMY-28190is the second example of bioactive homopolymersof amino acids obtained from natural origins. It is worthy to note that BMY-28190 is a larger polymer (n=51 -52) than e-poly-L-lysine (n=25-30) and is composed of D-amino acid in contrast to L-amino acid polymers of the latter. In addition, it is interesting that homopolypeptides consisting of more than 15 d-o^-DABresidues were active against HSV-1, while smaller polymers were inactive as revealed by partial hydrolysis experiments.
